View Cart  

OIG to Continue Investigating FDA’s REMS Program in 2013

During the coming year, the HHS Office of Inspector General (OIG) will continue examining the risk evaluation and mitigation strategies (REMS) program and expects to release findings next year, the office says in its fiscal 2013 work plan.

To View This Article:


Buy This Article Now

Add this article to your cart for $25.00